Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Anna Villar-Piqué
Based on 8 articles published since 2010
(Why 8 articles?)
||||
Expertise Level
The expertise of Anna Villar-Piqué ranks in the
  • Top 6.8%
  • ... of 89,464 published authors worldwide on Parkinson Disease
  • ... from 2010 through 2020
  • ... based on contributions to 8 articles on the topic.
Graphical view (beta)
Aliases Villar-Pique, Anna   ·   Villar-Piqué, Anna
Work Locations
Details
Most likely:    Universitat Gottingen      
2019
  • Department of Experimental Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center, Waldweg 33, Göttingen 37073, Germany. Electronic address: · Department of Experimental Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center, Waldweg 33, Göttingen 37073, Germany. · Institute of Neuroscience, Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. · Institute of Heath Sciences, China Medical University, 110112 Shenyang, P. R. China; Neural Plasticity and Repair Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, BMC A10, 221 84 Lund, Sweden. · Department of Neurology, University Medical Center and German Center for Neurodegenerative Diseases (DZNE), Robert-Koch Street 40, Göttingen 37075, Germany. · Department of Neuro- and Sensory Physiology, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center, Humboldtallee 23, Göttingen 37073, Germany. · Proteomics Group, Max Planck Institute of Experimental Medicine, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, Hermann Rein Street 3, Göttingen 37075, Germany. · Department of Experimental Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center, Waldweg 33, Göttingen 37073, Germany; Institute of Neuroscience, Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK; Max Planck Institute of Experimental Medicine, Hermann Rein Street 3, Göttingen 37075, Germany. Electronic address: · Pubmed 31269451
  • Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany. · Faculty of Medicine, University of Porto, Porto, Portugal. · Department for Functional Genomics, Center for Translational and Clinical Research, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia. · Max Planck Institute for Biophysical Chemistry, Göttingen, Germany. · Institute of Neuropathology, Bellvitge University Hospital, University of Barcelona, Bellvitge Biomedical Research Institute, Hospitalet de Llobregat; Biomedical Research Center of Neurodegenerative Diseases, Barcelona, Spain. · Department for Psychiatry and Psychotherapy, University Medical Center, Göttingen, Germany. · Institute of Neuroimmunology and Institute for Multiple Sclerosis Research, University Medical Centre Göttingen, Göttingen, Germany. · Max Planck Institute for Biophysical Chemistry, Laboratory of Chromatin Biochemistry, Göttingen, Germany. · Oxford Nanopore Technologies LTD, Oxford, United Kingdom. · Center for Neuroscience and Cell Biology and Faculty of Medicine, University of Coimbra, Coimbra, Portugal. · King Abdullah University of Science and Technology, Environmental Epigenetics Program, Thuwal, Saudi Arabia. · Development and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg. · Klinik für Psychosomatische Medizin und Psychotherapie, Universitätsmedizin Göttingen, Göttingen, Germany. · Department of Neurology, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany. · Institute of Neuroscience, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, United Kingdom. · Department of Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Göttingen Germany. · Structural Biology in Dementia, German Center for Neurodegenerative Diseases, Göttingen, Germany. · Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia. · Chronic Disease Research Center, NOVA Medical School, Lisboa, Portugal. · Max Planck Institute for Experimental Medicine, Göttingen, Germany. · Pubmed 30219847
  • Department of Neurology, University Medical Center Goettingen, Goettingen, Germany. · Department of Neurology, University Medical Center Goettingen, Goettingen, Germany. · Department of Neurology, University Medical Center Goettingen, Goettingen, Germany. · Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. · Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. · Second Department of Neurology, Comenius University, Bratislava, Slovakia. · Department of Neurology, University Medical Center Goettingen, Goettingen, Germany. · ADx NeuroSciences, Technologiepark 4, Ghent, Belgium. · Center for Neurodegenerative Research and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA. · Pubmed 30136097
2018
  • Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Goettingen, 37073, Göttingen, Germany. · European Neuroscience Institute, University Medical Center Göttingen, Göttingen, Germany. · Trans-synaptic Signaling Group, European Neuroscience Institute, Grisebachstrasse 5, 37077, Goettingen, Germany. · Max Planck Laboratory for Structural Biology, Chemistry and Molecular Biophysics of Rosario (MPLbioR, UNR-MPIbpC) and Instituto de Investigaciones para el Descubrimiento de Fármacos de Rosario (IIDEFAR, UNR-CONICET), Universidad Nacional de Rosario, Ocampo y Esmeralda, S2002LRK, Rosario, Argentina. · Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Goettingen, 37073, Göttingen, Germany. · Max Planck Institute for Experimental Medicine, Göttingen, Germany. · Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle Upon Tyne, NE2 4HH, UK. · Pubmed 30107856
2015
  • Department of Neurodegeneration and Restorative Research, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen 37073, Germany. · Instituto de Fisiologia, Faculty of Medicine, University of Lisbon, Lisboa 1649-028, Portugal. · Department of Neurodegeneration and Restorative Research, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen 37073, Germany. · Department of Neurodegeneration and Restorative Research, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen 37073, Germany. · Instituto de Fisiologia, Faculty of Medicine, University of Lisbon, Lisboa 1649-028, Portugal. · CEDOC, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa 1150, Portugal. · Pubmed 25874605
Probable:    Miscellaneous institutions in Gottingen      
2018
  • Department of Neurology, University Medical School, Göttingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. · Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany. · Department of Neurology, University Medical School, Göttingen, Germany. · Laboratory of Pharmacology, School of Health Sciences, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece. · Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland. · Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain. · Neurology Department, CHUC-Centro Hospitalar e Universitário de Coimbra, CNC- Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal. · Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain; Senior Consultant, Bellvitge University Hospital-IDIBELL, Department of Pathology and Experimental Therapeutics, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; UK Dementia Research Institute, London, UK. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain; Alzheimer Disease Research Unit, CIEN Foundation; Queen Sofia Foundation Alzheimer Center; Chronic Disease Programme Carlos III Institute of Health, Madrid, Spain. · Department of Neurosciences, Istituto Superiore di Sanità, Rome, Italy. · Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Department, Hospital Clínic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain. Electronic address: · Pubmed 29391125
2017
  • Department of Neurodegeneration and Restorative Research, University Medical Centre Göttingen , Göttingen , Germany. · Computational Biomedicine, Institute for Advanced Simulation IAS-5 and Institute of Neuroscience and Medicine INM-9, Jülich, Germany; Department of Oncology, Hematology, and Stem Cell Transplantation, Medical School, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany; Simulation Laboratory Biology - Jülich Supercomputing Centre (JSC), Jülich, Germany. · Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona , Barcelona, Spain. · Computational Biomedicine, Institute for Advanced Simulation IAS-5 and Institute of Neuroscience and Medicine INM-9 , Jülich , Germany. · Max Planck Laboratory for Structural Biology, Chemistry, and Molecular Biophysics of Rosario, Universidad Nacional de Rosario, Ocampo y Esmeralda, Santa Fe, Argentina; Instituto de Investigaciones para el Descubrimiento de Fármacos de Rosario UNR-Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina, Universidad Nacional de Rosario, Ocampo y Esmeralda, Rosario, Argentina. · Department of Neurodegeneration and Restorative Research, University Medical Centre Göttingen, Göttingen, Germany; Max Planck Institute for Experimental Medicine, Göttingen, Germany. · Pubmed 28289488
Probable:    Universitat Autonoma de Barcelona      
2013
  • Departament de Bioquímica i Biologia Molecular, Facultat de Biociències, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Spain; Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Spain. · Pubmed 23856334
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Anna Villar-Piqué in 2010-2020 about Parkinson Disease:

  • Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies. 2019
  • Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein. 2019
  • Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt-Jakob Disease and Synucleinopathy. 2019
  • Membrane binding, internalization, and sorting of alpha-synuclein in the cell. 2018
  • Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases. 2018
  • Copper(II) and the pathological H50Q α-synuclein mutant: Environment meets genetics. 2017
  • The Interplay between Alpha-Synuclein Clearance and Spreading. 2015
  • Protein aggregation propensity is a crucial determinant of intracellular inclusion formation and quality control degradation. 2013
Show List of Full Article Records
Google Searches

Learn more about Anna Villar-Piqué using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universitat Gottingen
Miscellaneous institutions in Gottingen
Universitat Autonoma de Barcelona
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universitat Gottingen
2019
  • Department of Experimental Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center, Waldweg 33, Göttingen 37073, Germany. Electronic address: · Department of Experimental Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center, Waldweg 33, Göttingen 37073, Germany. · Institute of Neuroscience, Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. · Institute of Heath Sciences, China Medical University, 110112 Shenyang, P. R. China; Neural Plasticity and Repair Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, BMC A10, 221 84 Lund, Sweden. · Department of Neurology, University Medical Center and German Center for Neurodegenerative Diseases (DZNE), Robert-Koch Street 40, Göttingen 37075, Germany. · Department of Neuro- and Sensory Physiology, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center, Humboldtallee 23, Göttingen 37073, Germany. · Proteomics Group, Max Planck Institute of Experimental Medicine, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, Hermann Rein Street 3, Göttingen 37075, Germany. · Department of Experimental Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center, Waldweg 33, Göttingen 37073, Germany; Institute of Neuroscience, Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK; Max Planck Institute of Experimental Medicine, Hermann Rein Street 3, Göttingen 37075, Germany. Electronic address: · Pubmed 31269451
  • Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany. · Faculty of Medicine, University of Porto, Porto, Portugal. · Department for Functional Genomics, Center for Translational and Clinical Research, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia. · Max Planck Institute for Biophysical Chemistry, Göttingen, Germany. · Institute of Neuropathology, Bellvitge University Hospital, University of Barcelona, Bellvitge Biomedical Research Institute, Hospitalet de Llobregat; Biomedical Research Center of Neurodegenerative Diseases, Barcelona, Spain. · Department for Psychiatry and Psychotherapy, University Medical Center, Göttingen, Germany. · Institute of Neuroimmunology and Institute for Multiple Sclerosis Research, University Medical Centre Göttingen, Göttingen, Germany. · Max Planck Institute for Biophysical Chemistry, Laboratory of Chromatin Biochemistry, Göttingen, Germany. · Oxford Nanopore Technologies LTD, Oxford, United Kingdom. · Center for Neuroscience and Cell Biology and Faculty of Medicine, University of Coimbra, Coimbra, Portugal. · King Abdullah University of Science and Technology, Environmental Epigenetics Program, Thuwal, Saudi Arabia. · Development and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg. · Klinik für Psychosomatische Medizin und Psychotherapie, Universitätsmedizin Göttingen, Göttingen, Germany. · Department of Neurology, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen, Germany. · Institute of Neuroscience, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, United Kingdom. · Department of Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Göttingen Germany. · Structural Biology in Dementia, German Center for Neurodegenerative Diseases, Göttingen, Germany. · Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia. · Chronic Disease Research Center, NOVA Medical School, Lisboa, Portugal. · Max Planck Institute for Experimental Medicine, Göttingen, Germany. · Pubmed 30219847
  • Department of Neurology, University Medical Center Goettingen, Goettingen, Germany. · Department of Neurology, University Medical Center Goettingen, Goettingen, Germany. · Department of Neurology, University Medical Center Goettingen, Goettingen, Germany. · Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. · Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. · Second Department of Neurology, Comenius University, Bratislava, Slovakia. · Department of Neurology, University Medical Center Goettingen, Goettingen, Germany. · ADx NeuroSciences, Technologiepark 4, Ghent, Belgium. · Center for Neurodegenerative Research and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA. · Pubmed 30136097
2018
  • Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Goettingen, 37073, Göttingen, Germany. · European Neuroscience Institute, University Medical Center Göttingen, Göttingen, Germany. · Trans-synaptic Signaling Group, European Neuroscience Institute, Grisebachstrasse 5, 37077, Goettingen, Germany. · Max Planck Laboratory for Structural Biology, Chemistry and Molecular Biophysics of Rosario (MPLbioR, UNR-MPIbpC) and Instituto de Investigaciones para el Descubrimiento de Fármacos de Rosario (IIDEFAR, UNR-CONICET), Universidad Nacional de Rosario, Ocampo y Esmeralda, S2002LRK, Rosario, Argentina. · Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Goettingen, 37073, Göttingen, Germany. · Max Planck Institute for Experimental Medicine, Göttingen, Germany. · Institute of Neuroscience, The Medical School, Newcastle University, Framlington Place, Newcastle Upon Tyne, NE2 4HH, UK. · Pubmed 30107856
2015
  • Department of Neurodegeneration and Restorative Research, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen 37073, Germany. · Instituto de Fisiologia, Faculty of Medicine, University of Lisbon, Lisboa 1649-028, Portugal. · Department of Neurodegeneration and Restorative Research, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen 37073, Germany. · Department of Neurodegeneration and Restorative Research, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen 37073, Germany. · Instituto de Fisiologia, Faculty of Medicine, University of Lisbon, Lisboa 1649-028, Portugal. · CEDOC, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa 1150, Portugal. · Pubmed 25874605
Miscellaneous institutions in Gottingen
2018
  • Department of Neurology, University Medical School, Göttingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. · Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany. · Department of Neurology, University Medical School, Göttingen, Germany. · Laboratory of Pharmacology, School of Health Sciences, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece. · Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland. · Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain. · Neurology Department, CHUC-Centro Hospitalar e Universitário de Coimbra, CNC- Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal. · Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain; Senior Consultant, Bellvitge University Hospital-IDIBELL, Department of Pathology and Experimental Therapeutics, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; UK Dementia Research Institute, London, UK. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. · Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain; Alzheimer Disease Research Unit, CIEN Foundation; Queen Sofia Foundation Alzheimer Center; Chronic Disease Programme Carlos III Institute of Health, Madrid, Spain. · Department of Neurosciences, Istituto Superiore di Sanità, Rome, Italy. · Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Department, Hospital Clínic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain. Electronic address: · Pubmed 29391125
2017
  • Department of Neurodegeneration and Restorative Research, University Medical Centre Göttingen , Göttingen , Germany. · Computational Biomedicine, Institute for Advanced Simulation IAS-5 and Institute of Neuroscience and Medicine INM-9, Jülich, Germany; Department of Oncology, Hematology, and Stem Cell Transplantation, Medical School, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany; Simulation Laboratory Biology - Jülich Supercomputing Centre (JSC), Jülich, Germany. · Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona , Barcelona, Spain. · Computational Biomedicine, Institute for Advanced Simulation IAS-5 and Institute of Neuroscience and Medicine INM-9 , Jülich , Germany. · Max Planck Laboratory for Structural Biology, Chemistry, and Molecular Biophysics of Rosario, Universidad Nacional de Rosario, Ocampo y Esmeralda, Santa Fe, Argentina; Instituto de Investigaciones para el Descubrimiento de Fármacos de Rosario UNR-Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina, Universidad Nacional de Rosario, Ocampo y Esmeralda, Rosario, Argentina. · Department of Neurodegeneration and Restorative Research, University Medical Centre Göttingen, Göttingen, Germany; Max Planck Institute for Experimental Medicine, Göttingen, Germany. · Pubmed 28289488
Universitat Autonoma de Barcelona
2013
  • Departament de Bioquímica i Biologia Molecular, Facultat de Biociències, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Spain; Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Spain. · Pubmed 23856334
Yearly article counts 03210101000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.